Chemed: Q4 Earnings Insights
Portfolio Pulse from Benzinga Insights
Chemed (NYSE:CHE) reported Q4 earnings with an EPS of $6.6, beating estimates by 6.0% against an expected $6.25. Revenue increased by $39.26 million from the previous year. The company has a history of surpassing EPS estimates, leading to a 9.0% share price increase the day after last quarter's earnings announcement.
February 27, 2024 | 9:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Chemed reported a Q4 EPS of $6.6, surpassing estimates by 6.0%, with a significant year-over-year revenue increase. Historically, earnings beats have led to positive stock price movements.
Chemed's history of surpassing earnings estimates and the positive reaction in stock price following last quarter's earnings beat suggest a likely short-term positive impact on CHE's stock price. The consistent performance in beating EPS estimates and the significant revenue growth year-over-year reinforce investor confidence and could lead to a similar positive market reaction.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100